2905 |
GLUTAMATE IONOTROPIC RECEPTOR NMDA TYPE SUBUNIT 2C |
GRIN2C |
GluN2C |
NMDAR2C |
NR2C |
138254 |
4587 |
ENSG00000161509 |
OTTHUMG00000044524 |
Glutamate [NMDA] receptor subunit epsilon-3 |
N-methyl D-aspartate receptor subtype 2C |
Glutamate receptor ionotropic, NMDA 2C |
Q14957 |
GLUTAMATE [NMDA] RECEPTOR SUBUNIT EPSILON 3 PRECURSOR (N-METHYL D- ASPARTATE RECEPTOR SUBTYPE 2C) (NR2C) (NMDAR2C). [SOURCE:UNIPROT/SWISSPROT;ACC:Q14957] |
NMDE3_HUMAN |
Target Subclass | TC:1.A.10.1.3 |
Target Class | Receptors |
Human Readable Name | DRUGGABLE GENOME |
Interpro Acc | IPR001320 |
Interpro Type | Domain |
Uniprot Evidence | 2: Evidence at transcript level |
Interpro Name | Ionotropic glutamate receptor |
Interpro Short Name | Iontro_glu_rcpt |
Uniprot Status | Swiss-Prot |
Gene Biotype | PROTEIN_CODING |
ION CHANNEL |
DRUGGABLE GENOME |
blocker (inhibitory) |
Trial Name | CNS-5161 |
Novel drug target | Novel Target |
Mechanism of Interaction | Glutamate [NMDA] receptor blocker |
n/a |
Trial Name | AM-101 |
Novel drug target | Novel Target |
Mechanism of Interaction | Glutamate [NMDA] receptor negative allosteric modulator |
blocker (inhibitory) |
Trial Name | AZD-6765 |
Novel drug target | Novel Target |
Mechanism of Interaction | Glutamate [NMDA] receptor blocker |
n/a |
Trial Name | dimiracetam, NT-11624 |
Novel drug target | Novel Target |
antagonist (inhibitory) |
Trial Name | V3381 |
Novel drug target | Novel Target |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
n/a |
Mechanism of Interaction | Glutamate [NMDA] receptor negative allosteric modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | Glutamate [NMDA] receptor negative allosteric modulator |
Direct Interaction | yes |
partial agonist (activating) |
Mechanism of Interaction | Glutamate [NMDA] receptor partial agonist |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | Glutamate [NMDA] receptor negative allosteric modulator |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
n/a |
Trial Name | Dimebon |
Novel drug target | Novel Target |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | Glutamate [NMDA] receptor positive allosteric modulator |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
partial agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | Glutamate [NMDA] receptor partial agonist |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Glutamate [NMDA] receptor antagonist |
Direct Interaction | yes |
GRIN2C | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
Q14957 | Uniprot Accession |
NMDE3_HUMAN | Uniprot Id |
GLUTAMATE [NMDA] RECEPTOR SUBUNIT EPSILON-3 | Uniprot Protein Name |
Interpro Acc | IPR001320 |
Interpro Type | Domain |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
GRIN2C | Gene Symbol |
Target Class | Receptors |
Target Subclass | TC:1.A.10.1.3 |
GRIN2C | Display Id |
ENSG00000161509 | Ensembl Gene Id |
GLUTAMATE [NMDA] RECEPTOR SUBUNIT EPSILON 3 PRECURSOR (N-METHYL D- ASPARTATE RECEPTOR SUBTYPE 2C) (NR2C) (NMDAR2C). [SOURCE:UNIPROT/SWISSPROT;ACC:Q14957] | Description |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
NMDAR2C | GENE_SYMBOL |
GRIN2C | GENE_SYMBOL |
Glutamate receptor ionotropic, NMDA 2C | UNIPROT |
ENSG00000161509 | Gene Symbol |
GRIN2C | Ensembl Id |
DRUGGABLE GENOME |
Glutamate receptor ionotropic, NMDA 2C | Gene Name |
Q14957 | UniProt ID |
ION CHANNEL |